ALFA Finder| Revenue growth | 14.7% consolidated growth for FY26. |
|---|---|
| Margins | Care Health combined ratio improved 120bps to 101.4% (Ind AS). |
| Order book | AUM crossed ₹10,000cr for Care Health. |
| Demand visibility | Strong tailwinds in retail health insurance and affordable housing finance. |
| Management confidence | High; transitioning from recovery to rebuilding phase with new leadership. |
Growth
FY26 Revenue grew 14.7% YoY (₹8,493cr vs ₹7,405cr). Care Health Insurance GWP grew 24% to ₹11,417cr.
Outlook
Planned capital infusion of ₹1,500cr. Care Health targets 18-24% growth and 100% combined ratio in 2 years.
Risks
Geopolitical impacts caused ₹64cr mark-to-market equity losses; regulatory compliance for promoter shareholding in insurance remains a focus.
Earnings Call filed with BSE, NSE: RELIGARE. Summary written with AI assistance from the document.
Religare Enterprises Ltd: key numbers
- Share price
- ₹230.78
- Market cap
- ₹7,956 Cr
- Revenue (annual)
- ₹8,459 Cr
- Net profit (annual)
- ₹85.96 Cr
- P/E (TTM)
- 343.0×Sector 20.8×
- Promoter holding
- 31.26%+0.70% QoQ
- FII holding
- 9.76%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Religare Enterprises Ltd
All →Religare Enterprises Business Update
Religare Finvest, a material subsidiary, resumed lending after RBI lifted its Corrective Action Plan. It disbursed its first Loan Against Property on 6 November 2026.
Religare Enterprises Board Meeting Date
Religare Enterprises intimated a board meeting on November 12, 2026 to consider unaudited standalone and consolidated results for the quarter ended September 30, 2026. The trading window stays closed until November 14, 2026.
Religare Enterprises Credit Rating
Religare Enterprises disclosed that CRISIL upgraded credit ratings for its subsidiary Religare Broking's Rs. 500 Crore bank facilities. Long-term rating moved to BBB+/Stable and short-term to A2+.
Religare Enterprises Debt & Borrowing: ₹150 Cr
Care Health Insurance, a material subsidiary of Religare, allotted listed subordinated debentures worth ₹150 Crore at a 10.50% coupon. The debentures mature in 2036, callable after five years.
- Value
- ₹150.0 Cr
Religare Enterprises Management Change
Religare Enterprises appointed Ms. Dipti Jayesh Khandelwal as Company Secretary and Compliance Officer w.e.f. October 31, 2026. She was designated as a Key Managerial Personnel.
Religare Enterprises Other Announcement
Religare Enterprises has filed its quarterly shareholding pattern for the period ending September 30, 2026, as per SEBI Regulation 31(1)(b).